Eam Global Investors LLC Concert Pharmaceuticals, Inc. Transaction History

Eam Global Investors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$4.27 - $7.2 $220,481 - $371,772	-51,635 Reduced 13.28%	337,095 $2.26 Million
Q2 2022 Aug 12, 2022	BUY	$2.8 - $6.36 $1.09 Million - $2.47 Million	388,730 New	388,730 $1.64 Million
Q1 2018 Jun 04, 2018	SELL	$19.24 - $28.03 $756,651 - $1.1 Million	-39,327 Closed	0 $0
Q4 2017 Jun 04, 2018	BUY	$13.96 - $29.05 $549,004 - $1.14 Million	39,327	39,327 $1.02 Million

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Global Investors LLC with notifications on news.